Asthma Roundup: Eosinophil, Tobacco Use, and More

The editors of Consultant360 have compiled a breakdown of top stories and recent asthma news. See what you may have missed.

Eosinophil count can predict omalizumab effectiveness.

The STELLAIR study assessed response to omalizumab using 3 criteria: physician evaluation, reduction of ≥40% in annual exacerbation rate and a combination of both. Read More

Tobacco is used more frequently among children with asthma, according to the CDC.

Using data from the 2016 Florida youth Tobacco Survey, researchers from the CDC examined rates of tobacco use among middle and high school students with and without asthma. Read More

Younger children experience asthma exacerbations more frequently in the spring and fall months.

In a study of 14,547 children and adolescents, researchers sought to identify predictors of childhood asthma exacerbations, examining the effects of age, sex, season, and eosinophil count. Read More

NAFLD can contribute to declines in lung function.

Hepatic fibrosis was also significantly associated with rapid forced vital capacity decline. Read More

See Also: Changing the Image of Tobacco (Podcast)